专题：Diabetes, Cardiovascular Risks, and Lipoproteins

This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
最新文献
Metabolic medicines and addiction: what GLP-1 receptor agonists might add to substance use care

article Full Text OpenAlex

Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )

article Full Text OpenAlex

Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia

article Full Text OpenAlex

Global epidemiology of diabetes and prediabetes in lean or non-obese patients with NAFLD: a systematic review and meta-analysis

article Full Text OpenAlex

The ‘10 commandments’ for the 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias

article Full Text OpenAlex

11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050

article Full Text OpenAlex

Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK Biobank

article Full Text OpenAlex

Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study

article Full Text OpenAlex

Diabetes duration, glycemic control, and risk of stroke and stroke subtypes: a nationwide prospective cohort study

article Full Text OpenAlex

Evaluation of the PREVENT risk assessment tool and visceral adiposity: Insights from the UK Biobank

article Full Text OpenAlex

近5年高被引文献
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 3812 FWCI1274.7883

2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023

review Full Text OpenAlex 2252 FWCI401.9332

2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024

review Full Text OpenAlex 1530 FWCI312.1161

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

review Full Text OpenAlex 1319 FWCI234.7834

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

review Full Text OpenAlex 1295 FWCI192.8034

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations

review Full Text OpenAlex 1014 FWCI135.8912

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association

review Full Text OpenAlex 866 FWCI174.6187

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025

review Full Text OpenAlex 860 FWCI486.9861

Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine

article Full Text OpenAlex 721 FWCI93.3469

The global burden of metabolic disease: Data from 2000 to 2019

article Full Text OpenAlex 692 FWCI153.1228